for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Relief Therapeutics And Neurorx Expand Clinical Trial Of RLF-100

June 8 (Reuters) - RELIEF THERAPEUTICS HOLDING SA:

* RELIEF THERAPEUTICS AND NEURORX EXPAND CLINICAL TRIAL OF RLF-100 TO ALL PATIENTS WITH CRITICAL COVID-19 AND RESPIRATORY FAILURE

* CLINICAL TRIAL TO ENROLL 144 PATIENTS TOTAL WITH EXPANSION TO ADDITIONAL SITES

* CLINICAL TRIAL EXPANDED TO PATIENTS TREATED WITH BOTH NONINVASIVE AND MECHANICAL VENTILATION IN CRITICAL COVID-19. Source text: bit.ly/3cGvpkn Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up